Nanohale AG (FYB) | WebDisclosure

Basculer en Français

8205	Companies
109437	Keywords
51603	Articles
60273	Press releases

Home
Companies
Nanohale AG

PRESS RELEASE

published on 09/17/2024 at 06:50, 1 month 17 days ago

Formycon will present clinical data on its ustekinumab biosimilar candidate FYB202 at the EADV Congress in Amsterdam and the UEG Week in Vienna
Formycon to present clinical data on ustekinumab biosimilar FYB202 at EADV Congress in Amsterdam and UEG Week in Vienna. Biosimilar for psoriasis and IBD in final approval phase

Clinical Data Biosimilar Formycon Ustekinumab Approval Process
BRIEF

published on 08/19/2024 at 14:16, 2 months 16 days ago

First Berlin Equity Research maintient sa note d'achat pour Formycon AG

Acheter Une Note Formycon Biosimilaires Résultats H1/24 Mise À Jour Des Revenus
BRIEF

published on 08/19/2024 at 14:16, 2 months 16 days ago

First Berlin Equity Research Maintains Buy Rating for Formycon AG

BUY Rating Biosimilars Formycon Revenue Update H1/24 Results
PRESS RELEASE

published on 08/19/2024 at 14:11, 2 months 16 days ago

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates Formycon AG (ISIN: DE000A1EWVY8) with H1/24 results, maintaining BUY rating and EUR 80 target price. Formycon raises FY/24 guidance due to stronger than expected results

First Berlin Equity Research BUY Rating Formycon AG H1/24 Results EUR 80 Target Price
BRIEF

published on 08/13/2024 at 06:55, 2 months 22 days ago

Formycon annonce un premier semestre solide avec des étapes importantes

Résultats Financiers Formycon Biosimilaires FYB201 Jalons Cliniques
BRIEF

published on 08/13/2024 at 06:55, 2 months 22 days ago

Formycon Reports Robust First Half-Year with Significant Milestones

Financial Results Biosimilars Clinical Milestones Formycon FYB201
PRESS RELEASE

published on 08/13/2024 at 06:50, 2 months 22 days ago

Formycon reports a strong first half-year with multiple milestones achieved
Formycon AG reports successful first half-year with key operational, clinical, and regulatory milestones achieved. Group revenue and EBITDA in line with expectations. Invitation to conference call today

Conference Call Revenue Formycon AG Milestones First Half-Year
BRIEF

published on 08/07/2024 at 06:55, 2 months 28 days ago

Formycon annonce une conférence téléphonique sur les résultats semestriels 2024 et la participation à la conférence des investisseurs

Résultats Semestriels Formycon AG Conférence Téléphonique Perspectives Financières Conférences Investisseurs
BRIEF

published on 08/07/2024 at 06:55, 2 months 28 days ago

Formycon Announces Conference Call on 2024 Half-Year Results and Investor Conference Participation

Conference Call Investor Conferences Formycon AG Half-year Results Financial Outlook
PRESS RELEASE

published on 08/07/2024 at 06:50, 2 months 28 days ago

Formycon invites to conference call on 2024 half-year results and announces participation in international investor conferences
Formycon schedules conference call on 2024 half-year results and confirms participation in investor conferences. Details on webcast and management presentations

Financial Results Conference Call Investor Conferences Biosimilars Formycon

Accesswire

Published on 11/05/2024 at 03:30, 1 hour 52 minutes ago

CORRECTION: Savencia Cheese USA Announces Voluntary Recall of Select Soft Ripened Cheeses
Published on 11/05/2024 at 00:00, 5 hours 22 minutes ago

Axcap Ventures Announces Upsizing of Private Placement
Published on 11/04/2024 at 23:00, 6 hours 22 minutes ago

Jericho Energy Ventures Announces Plan to Separate Hydrogen Platform from Traditional Energy Assets to Maximize Shareholder Value
Published on 11/04/2024 at 23:00, 6 hours 22 minutes ago

APEX/IFSA Global EXPO Showcases the Future of Aviation With Nearly 3,000 Industry ‎Professionals in Attendance
Published on 11/04/2024 at 22:45, 6 hours 37 minutes ago

Alphinat Announces a Profit of $160,597 for Fiscal Year Ended August 31, 2023

View all ACCESSWIRE

EQS Group

Published on 11/04/2024 at 22:20, 7 hours 1 minute ago

Adler Group S.A. announces the sale of its 62.78% stake in Brack Capital Properties N.V. to LEG Immobilien SE
Published on 11/04/2024 at 21:15, 8 hours 6 minutes ago

EQS-Adhoc: LEG Immobilien SE: Acquisition of Brack Capital Properties N.V. through the conclusion of a share purchase agreement and a tender commitment in the event of a public offer
Published on 11/04/2024 at 19:00, 10 hours 21 minutes ago

EQS-Adhoc: Salzgitter Aktiengesellschaft: Potential voluntary public takeover bid to the shareholders of Salzgitter AG
Published on 11/04/2024 at 19:00, 10 hours 21 minutes ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 28 OCTOBRE 2024 au 01 NOVEMBRE 2024
Published on 11/04/2024 at 19:00, 10 hours 21 minutes ago

PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF

Les Echos

Published on 11/04/2024 at 18:13, 11 hours 8 minutes ago

Thales : lancement de l’opération 2024 d’actionnariat salarié
Published on 11/04/2024 at 18:13, 11 hours 8 minutes ago

Thales: Launch of the 2024 Employee Share Ownership Plan
Published on 11/04/2024 at 18:11, 11 hours 10 minutes ago

Monthly disclosure of the total number of shares and voting rights - 31/10/2024
Published on 11/04/2024 at 18:11, 11 hours 10 minutes ago

Déclaration mensuelle des actions et droits de vote – 31/10/2024
Published on 11/04/2024 at 17:45, 11 hours 37 minutes ago

Disclosure of trading in own shares from October 29th, 2024, to November 1st, 2024. Detailed information per transaction.

View all LES ECHOS COMFI WIRE